| 产品名称: | Tissierella pigra |
|---|---|
| 商品货号: | TS257102 |
| <strong>Name </strong>: | \Tissierella pigra\ |
| <strong>DSM No. </strong>: | 105185, Proposed type strain dsm-105185 dsm105185 dsm 105185 Tissierella pigra |
| Strain designation : | WCA3-693-APC-4alpha |
| Isolated from : | pig, APC, 24 weeks old, feces |
| Country : | Germany Kranzberg (Bavaria) |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Genbank accession numbers : | 16S rRNA gene: MN537478 |
| Cultivation conditions : | Medium 339 Instead of Na-resazurin add 0,002 ml/ml Phenosafranin (Stock solution 1,25 mg/ml in H2O). After heating add 0,010 ml/ml Cystein-DTT (DL-Dithiothreitol)-solution (0,05 g/ml Cystein, 0,02 g/ml DTT)., anaerobic, N2CO2 + H2 (1 bar), 37°C Please follow special instructions: ;Cultivation of Anaerobes Complete DSMZ Media List |
| Summary and <br />additional information : | Proposed type strain. (Medium 339 Instead of Na-resazurin add 0,002 ml/ml Phenosafranin (Stock solution 1,25 mg/ml in H2O). After heating add 0,010 ml/ml Cystein-DTT (DL-Dithiothreitol)-solution (0,05 g/ml Cystein, 0,02 g/ml DTT)., 37°C, anaerobic, N2CO2 + H2 (1 bar)). Sampling Date: 30.08.2016 |
| Risk group : | 2 (classification according to German TRBA) |
| Restrictions : | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 Commercial use is completely excluded for this strain. For a request for commercial use please contact the depositor: tclavel@ukaachen.de |
| Other cultures : | All DSMZ cultures of the species |
| 产品名称: | Tissierella pigra |
|---|---|
| 商品货号: | TS257102 |
| <strong>Name </strong>: | \Tissierella pigra\ |
| <strong>DSM No. </strong>: | 105185, Proposed type strain dsm-105185 dsm105185 dsm 105185 Tissierella pigra |
| Strain designation : | WCA3-693-APC-4alpha |
| Isolated from : | pig, APC, 24 weeks old, feces |
| Country : | Germany Kranzberg (Bavaria) |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Genbank accession numbers : | 16S rRNA gene: MN537478 |
| Cultivation conditions : | Medium 339 Instead of Na-resazurin add 0,002 ml/ml Phenosafranin (Stock solution 1,25 mg/ml in H2O). After heating add 0,010 ml/ml Cystein-DTT (DL-Dithiothreitol)-solution (0,05 g/ml Cystein, 0,02 g/ml DTT)., anaerobic, N2CO2 + H2 (1 bar), 37°C Please follow special instructions: ;Cultivation of Anaerobes Complete DSMZ Media List |
| Summary and <br />additional information : | Proposed type strain. (Medium 339 Instead of Na-resazurin add 0,002 ml/ml Phenosafranin (Stock solution 1,25 mg/ml in H2O). After heating add 0,010 ml/ml Cystein-DTT (DL-Dithiothreitol)-solution (0,05 g/ml Cystein, 0,02 g/ml DTT)., 37°C, anaerobic, N2CO2 + H2 (1 bar)). Sampling Date: 30.08.2016 |
| Risk group : | 2 (classification according to German TRBA) |
| Restrictions : | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 Commercial use is completely excluded for this strain. For a request for commercial use please contact the depositor: tclavel@ukaachen.de |
| Other cultures : | All DSMZ cultures of the species |